MDSL
GIL icon

M.D. Sass LLC’s Gildan GIL Stock Holding History

M.D. Sass LLC’s Portfolio GIL Stock Details GIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-396,504
Closed -$22.1M – 44
2026
Q1 		$22.1M Buy
+396,504
New +$25.6M 1.67% 23
2020
Q1 		– Sell
-533,232
Closed -$15.7M – 41
2019
Q4 		$15.7M Buy
533,232
+124,814
+31% +$3.65M 3.73% 8
2019
Q3 		$14.5M Sell
408,418
-47,515
-10% -$1.79M 3.42% 8
2019
Q2 		$17.6M Sell
455,933
-334,415
-42% -$12.5M 4.08% 5
2019
Q1 		$28.4M Sell
790,348
-146,031
-16% -$5M 4.53% 4
2018
Q4 		$28.4M Sell
936,379
-17,269
-2% -$533K 4.83% 2
2018
Q3 		$29M Buy
+953,648
New +$27.7M 3.83% 9

Other funds holding GIL

Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $70.2B AUM 30.95% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

M.D. Sass LLC's GIL Position: Q2 2026 in Review

M.D. Sass LLC sold out of Gildan (GIL) in Q2 2026, closing a stake of 396,504 shares — an estimated $22.1M sold.

M.D. Sass LLC first reported a position in GIL in Q3 2018 and held it in 7 quarters. The position peaked at $29M in Q3 2018. 462 funds tracked by Wall St. Rank hold GIL as of Q2 2026.

  • M.D. Sass LLC reported no remaining Gildan position as of Q2 2026 after selling out during the quarter.
  • M.D. Sass LLC sold 396,504 Gildan shares in Q2 2026, an estimated $22.1M.
  • M.D. Sass LLC first reported a position in Gildan in Q3 2018 and held it in 7 quarters.
  • M.D. Sass LLC's Gildan position peaked at $29M in Q3 2018.
  • 462 funds tracked by Wall St. Rank held Gildan as of Q2 2026.

Based on M.D. Sass LLC's 13F filing for Q2 2026, filed 7 Aug 2026.